Anacor Pharmaceuticals Inc. (ANAC) and Medicis Pharmaceutical Corp. (MRX) Ink Collaboration Agreement
Anacor Pharmaceuticals Inc. and Medicis Pharmaceutical Corp. today announced they have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the patented, potential treatment of acne. “We are pleased to announce this important collaboration with Anacor,” Jonah Shacknai, chairman and CEO of Medicis stated in the press release. “Anacor and its scientists are well respected in the scientific community, and Medicis is proud to be among other significant organizations who have partnered with them to explore the pharmaceutical development of the Anacor boron chemistry platform. We will together be…